Wearable, Electronically Controlled Drug Delivery For The Treatment of Chronic Conditions
Why Controlled Drug Delivery Matters
At Remagine Labs, our mission is to transform treatment for chronic conditions like epilepsy through wearable, electronically controlled drug delivery. In this short video, our CEO and Monash University advisor share why precision dosing and patient-friendly design can make a real difference.
Our Partners
News
Leadership Team
-
Pat Kelly
CO-FOUNDER & CEO
-
Prof. Stan Skafidas
CO-FOUNDER & CTO
-
Marcio Souza
Board Member
-
Dr. Brian Pang
BOARD MEMBER
-
Dr. Heather Benson
ADVISOR
-
Dr. Steven Duvall
ADVISOR
-
Prof. Terence O'Brien
CLINICIAN ADVISOR
-
Prof. Patrick Kwan
CLINICIAN ADVISOR
-
Prof. Nicolas Voelker
ADVISOR